Ukraine's National Health Screening for 40+ Begins January 31st with 'Diia' App Invitations

National Health Screening Program for 40+ Launches

According to Міністерство Здоров'я: Ukraine's new national health screening program for citizens aged 40 and over will launch on January 31. The first invitations to participate will be sent via the government's 'Diia' mobile application. This initiative is part of a broader effort to modernize preventive care in the country. Invitations will be issued to individuals starting with those born on January 1st, and will be sent 30 days after their birthday. For example, a person born on January 2nd will receive their notification on February 1st.

About the Health Screening 40+ Program

The Health Screening 40+ program provides free basic check-ups aimed at the early detection of diseases. Each participant will undergo an annual assessment of heart health, blood sugar levels, and mental well-being. Upon applying to join the program, the state allocates 2000 hryvnias to cover the cost of these examinations.

Over 800 service points at medical facilities across the country are ready to conduct the Health Screening 40+ check-ups. The list of participating institutions is continually expanding, which is expected to significantly increase the accessibility of these medical services for the population.

As the program organizers note, 'Congratulations! The Health Screening service is now available to you. Take care of your health proactively - see the notification in the Diia app.'

This initiative aims to improve the overall health of Ukrainians and ensure the timely detection of illnesses.

The launch of the Health Screening 40+ program represents a significant step in improving Ukraine's healthcare system, as it promotes early disease detection and reduces health risks for the population. The initiative also underscores the importance of preventive examinations, which could lessen the future burden on the medical system.

By strengthening citizen health, the program has the potential to positively impact the quality of life for people over 40 and reduce the costs associated with treating advanced-stage diseases.